etomoxir has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gattullo, D; Mancardi, D; Pagliaro, P; Penna, C | 1 |
| Crew, MD; Dai, G; Gonzalez, FJ; Peters, JM; Portilla, D; Proia, AD | 1 |
2 other study(ies) available for etomoxir and Reperfusion Injury
| Article | Year |
|---|---|
Myocardial protection from ischemic preconditioning is not blocked by sub-chronic inhibition of carnitine palmitoyltransferase I.
Topics: Analysis of Variance; Animals; Carnitine O-Palmitoyltransferase; Epoxy Compounds; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Reperfusion Injury; Ventricular Pressure | 2005 |
Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Carnitine O-Palmitoyltransferase; Clofibrate; Creatinine; Enzymes; Epoxy Compounds; Ischemia; Kidney; Male; Mice; Mice, Knockout; Necrosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Renal Circulation; Reperfusion Injury; Transcription Factors | 2000 |